Blood markers for predicting sepsis outcomes
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at whether levels of certain substances in your blood (uric acid, albumin, and lactate) can predict how well you do when you have sepsis. It might help doctors better understand your condition and guide your care in the ICU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 65 years of age or older.
- You must have been diagnosed with sepsis (a severe infection that affects your whole body).
- You must be admitted to the intensive care unit (ICU) and stay there for at least 24 hours.
- You must have blood tests for uric acid, albumin, and lactate at the time of ICU admission.
- You must not have significant kidney injury or advanced liver disease at the start.
- You must not have active cancer or be receiving cancer treatment currently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two substances in urine (TIMP2 and IGFBP7) can help doctors predict which patients with sepsis-related kidney problems will get worse. If these markers work, doctors could identify high-risk patients earlier and treat them more aggressively.
This study looks at whether a blood protein called uromodulin can help predict how well people with sepsis and acute kidney injury will do. Sepsis is a serious infection, and acute kidney injury is a sudden drop in kidney function. The results may help doctors better understand and manage this condition.
This study is testing a combination of methods, including a bedside ultrasound of your kidneys, to help diagnose acute kidney injury that happens as a complication of sepsis. The goal is to find out if this approach can detect kidney problems early so doctors can treat them sooner.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This study looks at whether simple blood tests and a bedside score can help predict who is more likely to die from sepsis in the ICU. It does not involve any experimental drug or treatment—it just tracks existing lab results and outcomes.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.